Immune priming with the EZH2 inhibitor tazemetostat in B-cell lymphomas receiving CAR T-cell therapy.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Samuel Yamshon, Caitlin Gribbin, Yusuke Isshiki, Ioannis Karagiannidis, Sunjae Lee, Jizhi Yan, Gwynne Ozkan, Anna Alperovich, Barbara T. Ma, Christopher Hackett, Mateo Mejia Saldarriaga, Daniel Chimin Choi, Selina Chen-Kiang, John Paul Leonard, Ari Melnick, Nathan Hale Fowler, Juliet Naomi Barker, Giorgio Inghirami, Wendy Béguelin, Peter Martin
Institutions: Weill Cornell Medicine, NYU Langone Health
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Ipsen
OpenAlex ID: W7162497045
Cites:
Cited by:
Related to: